GL331 inhibits HIF-1α expression in a lung cancer model
- 28 February 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 302 (1), 95-100
- https://doi.org/10.1016/s0006-291x(03)00111-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage.Pharmaceutical Research, 2001
- Down-Regulation of Cyclin D1 Expression by Prostaglandin A2 Is Mediated by Enhanced Cyclin D1 mRNA TurnoverMolecular and Cellular Biology, 2000
- Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor ProgressionCritical Reviews in Biochemistry and Molecular Biology, 2000
- Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activityOncogene, 1998
- Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell LineAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposideCancer Letters, 1996
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Antitumor agents. 113. New 4.beta.-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase IIJournal of Medicinal Chemistry, 1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973